Reports
Reports
Sale
The global cell dissociation market size was valued at USD 456.1 million in 2023, driven by the increasing prevalence of cancer, and neurological disorders across the globe. The market size is anticipated to grow at a CAGR of 15% during the forecast period of 2024-2032 to achieve a value of USD 1606.6 million by 2032.
The process of cell dissociation is crucial for studying tissue phenotypes. The technique used to extract cells from solid tissues has a significant impact on the types of cells obtained. The methodology employed also affects any biases introduced that can influence cell surface protein phenotypes or gene expression.
The approval of pembrolizumab (Keytruda, Merck) by the Food and Drug Administration on November 16, 2023, for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma is poised to significantly impact the global cell dissociation market.
Stem cell research, with its focus on the potential medical applications of stem cells, has been witnessing increased emphasis and demand for creating cell-based therapies, bolstering the global cell dissociation market growth. As stem cell research expands, the necessity for advanced techniques like cell dissociation becomes paramount, particularly in isolating and harvesting stem cells from tissues. The efficiency of cell dissociation methods is crucial for maintaining the viability and functionality of stem cells during the isolation process.
The FDA approval of pembrolizumab, specifically for a subtype of cancer, is expected to fuel the expansion of the market for research related to gastric and gastroesophageal junction adenocarcinoma. This expansion is anticipated to drive a surge in research activities, leading to an increased demand for cell dissociation tools and technologies. The combination of growing stem cell research and the specific market expansion prompted by the approval of pembrolizumab aligns with the trajectory of increased clinical trials, FDA approvals, and strategic initiatives by leading companies, collectively contributing to the robust growth of the global cell dissociation market.
Market Breakup by Type
Market Breakup by Tissue Type
Market Breakup by End User
Market Breakup by Region
The market has been witnessing substantial growth driven by the increasing prevalence of various medical conditions including cancer, neurological disorders, cardiovascular diseases, genetic disorders, rare diseases, infectious diseases, regenerative medicine, and autoimmune diseases. Researchers leverage cell dissociation techniques across these diverse fields to isolate and study specific cell types, unravelling disease mechanisms and testing potential therapies.
The rising interest in personalized medicine and regenerative medicine is acting as a catalyst, propelling the demand for cell dissociation solutions. Furthermore, the market is benefiting from continuous technological advancements in cell dissociation products, particularly the development of reagents and kits that offer efficient cell dissociation. These innovations are anticipated to boost their usage in research and development applications.
Geographically, North America has been a leading regional market, expected to maintain its dominance throughout the forecast period as well. This dominance can be attributed to the increasing prevalence of cancer and neurological disorders in the region, driving a surge in research activities. The pursuit of finding the most suitable treatments for patients suffering from various medical conditions is bolstering market growth in North America.
The global cell dissociation market is poised for significant expansion as it becomes an integral component of cutting-edge research endeavours, addressing the growing demand for advanced solutions in the diagnosis, treatment, and understanding of complex diseases.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Tissue Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cell Dissociation Market Overview
3.1 Global Cell Dissociation Market Historical Value (2017-2023)
3.2 Global Cell Dissociation Market Forecast Value (2024-2032)
4 Global Cell Dissociation Market Landscape
4.1 Global Cell Dissociation: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cell Dissociation: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Cell Dissociation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cell Dissociation Market Segmentation
6.1 Global Cell Dissociation Market by Type
6.1.1 Market Overview
6.1.2 Trypsin
6.1.3 Papain
6.1.4 DNase
6.1.5 Hyaluronidase
6.1.6 Instruments
6.2 Global Cell Dissociation Market by Tissue Type
6.2.1 Market Overview
6.2.2 Connective Tissue
6.2.3 Epithelial Tissue
6.3 Global Cell Dissociation Market by End User
6.3.1 Market Overview
6.3.2 Pharma
6.3.3 Biopharma
6.3.4 Research Institutes
6.4 Global Cell Dissociation Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cell Dissociation Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cell Dissociation Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cell Dissociation Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cell Dissociation Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cell Dissociation Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Merck KGaA
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Danaher Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Thermo Fisher Scientific, Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Corning Incorporated
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Becton, Dickinson and Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 STEMCELL Technologies
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Promo Cell GmbH
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Miltenyi Biotec
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 ATCC
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 HiMedia Laboratories
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 456.1 million in 2023, driven by the rising interest in personalized medicines.
The market is anticipated to grow at a CAGR of 15% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1606.6 million by 2032.
The market growth is driven by FDA approvals and the increasing prevalence of medical conditions requiring personalized treatment.
The market growth is influenced by the increased research and development activities.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Different types of cell dissociations include trypsin, papain, DNase, hyaluronidase, and instruments.
Different types of tissues include connective tissue and epithelial tissue.
The end users in the market include pharma, biopharma, and research institutes.
Key players involved in the market are Merck KGaA, Danaher Corporation, Thermo Fisher Scientific, Inc, Corning Incorporated, Becton, Dickinson and Company, STEMCELL Technologies, Promo Cell GmbH, Miltenyi Biotec, ATCC, and HiMedia Laboratories.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.